Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹47,412Qualified 198A HSIDC SECTOR 3 KARNAL HARYANA 132001 | KARNAL | HARYANA | 132001 | L1 | Qualified MSE, MII, Category: General | |
| 2 | L2₹1.2 L+₹68,484 (144.4%)Qualified CHANDIGARH CHANDIGARH 160047 | CHANDIGARH | CHANDIGARH | 160047 | L2 | Qualified MII |
Tender Value
₹47,412
EMD Value
Exempted
Closing Date
16 Sept 2025, 1:00 pmClosed
Ondansetron Tablet (Q2) ( ( 3 3 ))
8195590
GEM/2025/B/6546911
Two Packet Bid
Ondansetron Tablet (Q2) ( ( 3 3 ))
GeM Contract
Kaur 160031, Government Medical College & Hospital Sector 32, 160031Quanti ty Delivery to start after __________ Delivery to be completed by
Total value wise evaluation
PRODUCT
Awarded to SARTHAK BIOTECH PRIVATE LIMITED
₹47,412
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Vomiquit-8 Md--SARTHAK BIOTECH PRIVATE LIMITED Ondansetron Tablet 8 mg | Vomiquit-8 Md--SARTHAK BIOTECH PRIVATE LIMITED / Ondansetron Tablet | HSN not specified by seller | 175,600 tablet(s) | 0.27 | 47,412 |
3 documents required · 3 mandatory
₹31
₹2 L
Exempted
27 Nov 2025
26 Aug 2025
16 Sept 2025
Vomiquit-8 Md--SARTHAK BIOTECH PRIVATE LIMITED Ondansetron Tablet 8 mg | Brand:Vomiquit-8 Md--SARTHAK BIOTECH PRIVATE LIMITED | Model:Ondansetron Tablet | HSN:HSN not specified by seller | Qty:175,600 tablet(s) | UnitPrice:0.27 | Amount:47,412
contract_GEMC-511687759205320.pdf
GEM_CONTRACT • 0.11 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8195590.pdf
GEM_BID
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .